AbbVie Inc (ABBV) financials · rev $61.16B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
AbbVie Inc (ABBV) rev $61.16B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $61.16B | $56.33B |
| Cost of Revenue | $18.20B | $16.90B |
| Gross Profit | $42.96B | $39.43B |
| Operating Income | $15.07B | $9.14B |
| Net Income | $4.23B | $4.28B |
| EPS (Diluted) | $2.36 | $2.39 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $133.96B | $135.16B |
| Current Assets | $29.06B | $25.58B |
| Cash & Equivalents | $5.23B | $5.52B |
| Inventory | $4.95B | $4.18B |
| PP&E | $5.63B | $5.13B |
| Total Liabilities | $137.23B | $131.84B |
| Current Liabilities | $43.29B | $38.75B |
| Short-term Debt | $2.50B | N/A |
| Long-term Debt | $64.50B | $66.84B |
| Total Debt | $65.00B | $67.14B |
| Shareholders' Equity | -$3.27B | $3.33B |
| Retained Earnings | -$15.49B | -$7.90B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $19.03B | $18.81B |
| CapEx | $1.21B | $974.0M |
| Investing Cash Flow | -$6.64B | -$20.82B |
| Financing Cash Flow | -$12.72B | -$5.21B |
| Dividends Paid | $11.66B | $11.03B |
| Net Change in Cash | -$295.0M | -$7.29B |
| Free Cash Flow | $17.82B | $17.83B |
FAQ
What is ABBV P/E and revenue?
AbbVie Inc (ABBV) rev $61.16B.
What is ABBV revenue?
AbbVie Inc last cached revenue is $61.16B (FY2025).
Is ABBV profitable?
AbbVie Inc last cached net income is $4.23B (FY2025).
What are ABBV total assets?
AbbVie Inc last cached total assets are $133.96B (FY2025).
What is ABBV free cash flow?
AbbVie Inc last cached free cash flow is $17.82B (FY2025).
Not investment advice. Cached statements, not a live tape.